EUVIMEDEUVIMED entdecken
Open Access

Prevalence, symptomology, and correlates of curable sexually transmitted infections among pregnant women in Eastern Cape, South Africa

Natalie G Shaetonhodi iD, Alex de Voux, Chibuzor M Babalola, Dvora Joseph Davey, Mandisa M Mdingi, Ranjana M S Gigi, Remco P H Peters, Freedom Mukomana, Jeffrey D Klausner iD, Andrew Medina-Marino

International Journal of STD & AIDS · 2025

DOI: 10.1177/09564624251347484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of STD & AIDS, 2025. Verfasst von Natalie G Shaetonhodi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Sexually Transmitted Diseases, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NICHD NIH HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Curable sexually transmitted infections (STIs) contribute to adverse maternal and neonatal outcomes. Syndromic management is standard care in South Africa. We evaluated prevalence, symptomology, and correlates of curable STIs, among pregnant women in Eastern Cape, South Africa.

Methods

We conducted a cross-sectional analysis using baseline data from a randomized controlled trial of pregnant women attending their first antenatal care visit at public clinics in Buffalo City Municipality (2021–2024). Participants were tested for Chlamydia (C.) trachomatis , Neisseria (N.) gonorrhoeae , Trichomonas (T.) vaginalis using GeneXpert point-of-care tests and for syphilis using Alere Determine TP rapid test. Symptoms were self-reported and clinically-observed. Adjusted prevalence ratios were estimated using Poisson regression models with robust standard errors.

Results

Among 1491 participants (median age: 28 years (IQR: 24–33); gestational age: 13 weeks (IQR: 8–18); HIV prevalence: 30%), STI prevalence was 27.6% (95% CI: 25.3–29.9): C. trachomatis 14.7%, N. gonorrhea 5%, T. vaginalis 10.2%, syphilis 3.4%. Women with HIV had higher STI prevalence (32.8% vs 25.3%, p = .003), particularly for T. vaginalis (17% vs 7.3%, p < .001); 20.1% of women with C . trachomatis , N. gonorrhea , and/or T. vaginalis were symptomatic, and 63% of symptomatic women tested STI-negative. Younger age, lower education, multiple sex partners and unknown HIV-serostatus of partners were associated with increased STI prevalence.

Conclusion

We observed a high prevalence of STIs, particularly among women with HIV, with many asymptomatic cases; emphasizing the need for integrated point-of-care testing to ensure timely treatment, reduce antibiotic overuse, and improve maternal and neonatal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sexually Transmitted DiseasesPregnancy Complications, InfectiousHumansFemaleSouth AfricaPregnancyAdultPrevalenceCross-Sectional StudiesGonorrheaSyphilisChlamydia InfectionsPrenatal CareYoung AdultChlamydia trachomatisNeisseria gonorrhoeaeHIV InfectionsPregnant People

Stichwörter der Autor:innen

Sexually transmitted infectionsSouth Africaaetiological testingantenatal care

Autor:innen und Institutionen

  • Division of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
  • Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Division of Infectious Diseases, Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Research Unit, Foundation for Professional Development, East London, South Africa.
  • Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

ORCID-Profile: Natalie G Shaetonhodi, Jeffrey D Klausner

Förderung

  • NIAID NIH HHS
  • NICHD NIH HHS
  • NIAAA NIH HHS
  • National Institute of Health

Zitieren

APA

Shaetonhodi, N. G., de Voux, A., Babalola, C. M., Joseph Davey, D., Mdingi, M. M., Gigi, R. M. S., Peters, R. P. H., Mukomana, F., Klausner, J. D., & Medina-Marino, A. (2025). Prevalence, symptomology, and correlates of curable sexually transmitted infections among pregnant women in Eastern Cape, South Africa. International Journal of STD & AIDS. https://doi.org/10.1177/09564624251347484

Vancouver

Shaetonhodi NG, de Voux A, Babalola CM, Joseph Davey D, Mdingi MM, Gigi RMS, et al. Prevalence, symptomology, and correlates of curable sexually transmitted infections among pregnant women in Eastern Cape, South Africa. International Journal of STD & AIDS. 2025. doi:10.1177/09564624251347484

BibTeX
@article{Shaetonhodi2025,
  author = {Shaetonhodi, Natalie G and de Voux, Alex and Babalola, Chibuzor M and Joseph Davey, Dvora and Mdingi, Mandisa M and Gigi, Ranjana M S and Peters, Remco P H and Mukomana, Freedom and Klausner, Jeffrey D and Medina-Marino, Andrew},
  title = {Prevalence, symptomology, and correlates of curable sexually transmitted infections among pregnant women in Eastern Cape, South Africa},
  journal = {International Journal of STD & AIDS},
  year = {2025},
  doi = {10.1177/09564624251347484}
}
Kostenlos starten →